Display options
Share it on

Genome Med. 2013 Apr 29;5(4):35. doi: 10.1186/gm439. eCollection 2013.

Plasma-seq: a novel strategy for metastatic prostate cancer analysis.

Genome medicine

Caitlin Farris, Jeffrey M Trimarchi

Affiliations

  1. Department of Genetics, Development and Cell Biology, 2114 Molecular Biology, Iowa State University, Ames, IA 50011, USA.

PMID: 23673197 PMCID: PMC3706850 DOI: 10.1186/gm439

Abstract

UNLABELLED: Personalized genomics will only be useful for monitoring the prognosis of patients with cancer when it becomes much more cost-effective and quicker to apply. A recent study brings this closer to reality with the development of plasma-seq, a rapid, low-cost method that sequences the circulating DNA present in the peripheral blood of patients with cancer. The power of this technique is demonstrated with the examination of tumor genomes from patients with prostate cancer.

SEE RELATED RESEARCH ARTICLE: http://genomemedicine.com/content/5/4/30.

References

  1. Clin Cancer Res. 2011 Jun 15;17(12):3903-12 - PubMed
  2. Cancer Cell. 2010 Jul 13;18(1):11-22 - PubMed
  3. Future Oncol. 2009 Dec;5(10):1555-84 - PubMed
  4. Lancet. 2008 May 17;371(9625):1710-21 - PubMed
  5. CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300 - PubMed
  6. Genome Med. 2013 Apr 05;5(4):30 - PubMed
  7. Ann Intern Med. 2012 Jul 17;157(2):120-34 - PubMed
  8. Sci Transl Med. 2012 May 30;4(136):136ra68 - PubMed
  9. Nature. 2011 Feb 10;470(7333):214-20 - PubMed
  10. Lancet Oncol. 2012 Nov;13(11):1114-24 - PubMed

Publication Types